期刊文献+

新城疫病毒mRNA疫苗的构建及鉴定

Construction and identification of Newcastle disease virus mRNA vaccine
原文传递
导出
摘要 信使RNA(messenger RNA,mRNA)的核酸疫苗是近年来兴起的一种新型疫苗技术。新城疫病毒(Newcastle disease virus,NDV)的血凝素-神经氨酸酶(HN)是NDV的主要保护性抗原,可诱导机体产生中和抗体,是新城疫(Newcastle disease,ND)新型疫苗研发的重要靶点。本研究将NDV HN基因连接到含有T7启动子的载体中,并在其5′UTR和3′UTR分别引入人-β球蛋白的非编码区域以增强转录的mRNA稳定性,经质粒线性化、体外转录、cap加帽处理、mRNA纯化制备NDV HN-mRNA,将其转染至HEK-293T细胞中验证NDV HN-mRNA的表达效果,Western blot和免疫荧光试验结果表明构建mRNA候选疫苗可在HEK-293T细胞中高效表达抗原蛋白,为ND新型疫苗的研发提供新的思路。 The nucleic acid vaccine of the messenger RNA(mRNA)is a new type of vaccine technology that has emerged in recent years.Newcastle disease virus(NDV)hemoglobin-neuraminidase(HN)is the main protective antigen of the Newcastle disease virus and an important target for new types of vaccines for Newcastle disease(ND).It can induce the body to produce neutral antibodies.Therefore,this study will clone the NDV HN gene to the carrier containing the T7 promoter and introduce the non-encoded area of theβglobulin in its 5'UTR and 3'UTR to enhance the mRNA stability of the transcription.NDV HN mRNA was prepared by plasmid linearization,in vitro transcription,cap processing,and mRNA purification,then it was transfected into HEK-293T cells to verify the expression effect of NDV HN mRNA.The results of Western blot and immune fluorescence showed that the mRNA candidate vaccine can highly express antigen protein in HEK-293 Tcells,providing new ideas for the research and development of novel ND vaccines.
作者 崔苗苗 陈凯楠 李金斗 丁佳欣 陈铭桦 冯嘉轩 周铁忠 舒秀伟 刘晓雷 丁壮 CUI Miaomiao;CHEN Kainan;LI Jindou;DING Jiaxin;CHEN Minghua;FENG Jiaxuan;ZHOU Tiezhong;SHU Xiuwei;LIU Xiaolei;DING Zhuang(Key Laboratory for Zoonosis Research of Ministry of Education,College of Veterinay Medicine,Jilin University,Changchun 130062,China;Key Laboratory of Liaoning Province,College of Animal Husbandry and Veter-inary Medicine,Jinzhou Medical University,Jinzhou,Liaoning 121000,China;Liaoning Yikang Biotechnology Co.,Ltd.,Liaoyang,Liaoning 111000,China)
出处 《中国兽医学报》 CAS CSCD 北大核心 2023年第12期2480-2485,共6页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目(32072860) 吉林省科技厅重点研发计划资助项目(20230202082NC,20200402037NC) 辽宁省科技厅重点研发资助项目(2021JH2/10200009) 长春市科技局重点研发计划资助项目(21ZGN17) 辽宁省民生科技计划资助项目(2021JH2/10200009)。
关键词 新城疫病毒 HN蛋白 体外转录 mRNA疫苗 Neweastle disease virus HN protein in vitro transcription mRNA vaccine
  • 相关文献

参考文献3

二级参考文献38

  • 1Schlake T, Thess A, Fotin Mleczek M, et al. Developing mRNA vaccine technologies[J]. RNA Biol, 2012, 9(11): 1319-1330.
  • 2Kramps T, Probst J. Messenger RNA-based vaccines: progress, challenges, applications[J]. Wiley Interdiscip Rev RNA, 2013, 4(6): 737-749.
  • 3McIvor RS. Therapeutic delivery of mRNA: the medium is the message[J]. Mol Ther, 2011, 19(5): 822-823.
  • 4Deering RP, Kommareddy S, Ulmer JB, et al. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines[J]. Expert Opin Drug Deliv, 2014, 11(6): 885-899.
  • 5Kawai T, Akira S. The role of pattern recognition receptors in innate immunity: update on Toll-like receptors[J]. Nat Immunol, 2010, 11(5): 373-384.
  • 6Sahin U, Karika K, Ttireci O. mRNA-based therapeutics- developing a new class of drugs[J]. Nat Rev Drug Discov, 2014, 13(10): 759-780.
  • 7Yamamoto A, Kormann M, Rosenecker J, et al. Current prospects for mRNA gene delivery[J]. Eur J Pharm Biopharm, 2009, 71(3): 484-489.
  • 8Zhao Y, Moon E, Carpenito C, et al. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor[J]. Cancer Res, 2010, 70(22): 9053-9061.
  • 9Petsch B, Schnee M, Vogel AB, et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection[J]. Nat Biotechnol, 2012, 30(12): 1210-1216.
  • 10Mays LE, Ammon Treiber S, Mothes B, et al. Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism[J]. J Clin Invest, 2013, 123(3): 1216-1228.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部